Literature DB >> 7192534

Inhibition of cellular alpha and virally induced deoxyribonucleic acid polymerases by the triphosphate of acyclovir.

M H St Clair, P A Furman, C M Lubbers, G B Elion.   

Abstract

The effect of the triphosphate of 9-(2-hydroxyethoxymethyl)guanine (acyclovir, acycloguanosine) on cellular alpha deoxyribonucleic acid (DNA) polymerases (DNA nucleotidyltransferases), DNA polymerases of several members of the herpes group, vaccinia virus DNA polymerase, and Friend leukemia virus ribonucleic acid-dependent DNA polymerase was examined. Several viruses, which were found to be susceptible to acyclovir, were found to induce DNA polymerases which were sensitive to acyclovir triphosphate (acyclo-GTP). Human cytomegalovirus and the H29R strain of herpes simplex virus type 1, however, were found to be relatively insusceptible to acyclovir, even though their induced DNA polymerases were inhibited by low concentrations of acyclo-GTP. The amount of acyclovir anabolized to acyclo-GTP was significantly lower for human cytomegalovirus and H29R than for the more susceptible viruses. Vaccinia virus and Friend leukemia virus induced DNA polymerases which were insensitive to inhibition by low concentrations of acyclo-GTP, anabolized little acyclovir to acyclo-GTP, and were found to be insensitive to inhibition by acyclovir. Uninfected WI-38 cells were not susceptible to inhibition by acyclovir, anabolized little acyclovir to acyclo-GTP, and had an alpha DNA polymerase which was insensitive to inhibition by low concentrations of acyclo-GTP.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7192534      PMCID: PMC284085          DOI: 10.1128/AAC.18.5.741

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Poly (A) sequences of vaccinia virus messenger RNA: nature, mode of addition and function during translation in vitra and in vivo.

Authors:  J R Nevins; W K Joklik
Journal:  Virology       Date:  1975-01       Impact factor: 3.616

2.  Human cytomegalovirus. III. Virus-induced DNA polymerase.

Authors:  E S Huang
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

3.  [Production of substantial amounts of Friend leukemia virus by a suspension tissue culture line (Eveline suspension cells) (author's transl)].

Authors:  E Seifert; M Claviez; H Frank; G Hunsmann; H Schwarz; W Schäfer
Journal:  Z Naturforsch C Biosci       Date:  1975 Sep-Oct

Review 4.  Enzyme induction by viruses.

Authors:  S Kit; D R Dubbs
Journal:  Monogr Virol       Date:  1969

5.  Characterization of herpes simplex virus-induced deoxyribonucleic acid polymerase.

Authors:  A Weissbach; S C Hong; J Aucker; R Muller
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

6.  RNA-dependent DNA polymerase activity of RNA tumor viruses. I. Directing influence of DNA in the reaction.

Authors:  J Hurwitz; J P Leis
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

7.  Rapid cell culture assay technic for murine leukaemia viruses.

Authors:  R H Bassin; N Tuttle; P J Fischinger
Journal:  Nature       Date:  1971-02-19       Impact factor: 49.962

8.  Kinetics and intermediates in the intracellular synthesis of bacteriophage T4 deoxyribonucleic acid.

Authors:  S Altman; L S Lerman
Journal:  J Mol Biol       Date:  1970-06-14       Impact factor: 5.469

9.  On the fidelity of DNA replication. Lack of exodeoxyribonuclease activity and error-correcting function in avian myeloblastosis virus DNA polymerase.

Authors:  N Battula; L A Loeb
Journal:  J Biol Chem       Date:  1976-02-25       Impact factor: 5.157

10.  Separation of a new deoxyribonucleic acid polymerase from vaccinia-infected HeLa cells.

Authors:  K I Berns; C Silverman; A Weissbach
Journal:  J Virol       Date:  1969-07       Impact factor: 5.103

View more
  23 in total

1.  Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.

Authors:  G B Elion
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

2.  Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approach.

Authors:  Janice Elaine Y Silverman; Mihai Ciustea; Abigail M Druck Shudofsky; Florent Bender; Robert H Shoemaker; Robert P Ricciardi
Journal:  Antiviral Res       Date:  2008-06-20       Impact factor: 5.970

Review 3.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

4.  Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir.

Authors:  S C Stanat; J E Reardon; A Erice; M C Jordan; W L Drew; K K Biron
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of acyclovir.

Authors:  O L Laskin
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

6.  Characterization of an herpes simplex virus type 2 mutant, which is resistant to acycloguanosine and causes fusion of BSC1 cells.

Authors:  E Katz; E Margalith
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication.

Authors:  M J Tocci; T J Livelli; H C Perry; C S Crumpacker; A K Field
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

8.  Inhibition of cellular alpha DNA polymerase and herpes simplex virus-induced DNA polymerases by the triphosphate of BW759U.

Authors:  M H St Clair; W H Miller; R L Miller; C U Lambe; P A Furman
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

9.  Intranuclear accumulation of subgenomic noninfectious human cytomegalovirus DNA in infected cells in the presence of ganciclovir.

Authors:  F M Hamzeh; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

10.  Metabolism of acyclovir in virus-infected and uninfected cells.

Authors:  P A Furman; P de Miranda; M H St Clair; G B Elion
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.